Robert Francomano Email & Phone Number

Dublin City, County Dublin, Ie

As the Chief Commercial Officer at SynOx Therapeutics Limited, a pioneering late-stage clinical biopharmaceutical company, my role is to architect and drive the strategic transformation of SynOx into a global commercial enterprise. I am primarily focused on spearheading the CSF1(R) inhibiting monoclonal antibody emactuzumab’s global commercialization effort for Tenosynovial Giant Cell Tumor (TGCT) and other subsequent oncologic indications while delivering impactful solutions that meet the needs of patients worldwide.

New York, Ny, Us

Growth-focused executive charged with building a comprehensive commercial infrastructure & capability from concept to commercialization. Served as the key catalyst for the corporate transition from clinical stage to that of a revenue generating entity. By strategically orchestrating business planning initiatives, successfully developed the groundwork for achieving sustainable revenue growth while maximizing profitability margins.

New York, New York, Us

Led the transformation of Stemline from a clinical-stage entity to one with a full commercial & Medical capability and infrastructure. Established from the ground floor up high-performing Marketing, Diagnostics, Sales, Access & Reimbursement, Operations and Medical Affairs functions for U.S. & global markets.As demonstrated by Bloomberg data analysis, spearheaded the top-ranked inaugural commercial launch among 72 leading biotechnology organizations, achieving unparalleled stock value growth as a percentage.

Illinois, Us

Headed up the development and execution of the go-to-market strategy for the global launch of pacritinib in myelofibrosis. Developed the asset’s life cycle strategy to expand labeled indications to both solid and hematologic malignancies via a multifactorial analytics process. Served as Chair for the Joint Commercialization Committee (JCC).

Delivered strategic counsel to VP and C-Suite Executives regarding oncology and rare disease areas for Top 10 pharmaceutical and biotechnology organizations. Adeptly redirected strategic focus related to seemingly insurmountable challenges, leading to greater corporate effectiveness.

New York, New York, Us

Prepared and delivered launch readiness in 66 global markets while producing successful on-time, first-in-class product launches. Developed and led the execution of short and long-term global marketing strategy for assets treating Mantle Cell Lymphoma and Renal Cell Carcinoma.

Brentford, Middlesex, Gb

Oversaw commercial aspect of eight extensive clinical development programs inclusive of IND-enabling, phase II & III trials. Developed the global commercial strategy for emerging oncology assets from candidate selection through phase 3.

Management Executive Education, Computer Science & Artificial Intelligence Laboratory

Executive Education - Global Positioning

Master Of Business Administration (M.B.A.), Pharmaceutical Marketing And Management

B.S., Marketing/Marketing Management, General